Assignee
LI YUN-LONG
US·8 granted patents·3 pending applications·478 citations·filing 2007–2012
Top patents by PatentIndex Score
11 records- 0199US8604043B23-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitorsLI YUN-LONG·Filed 2010·Granted Dec 10, 2013·117 cites·20 claims
- 0298US9199982B2Heterocyclylamines as PI3K inhibitorsLI YUN-LONG·Filed 2012·Granted Dec 1, 2015·52 cites·15 claims
- 0398US8940752B2Pyrimidinones as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Jan 27, 2015·62 cites·16 claims
- 0498US8309718B24-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitorsLI YUN-LONG·Filed 2008·Granted Nov 13, 2012·109 cites·35 claims
- 0597US9096600B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsLI YUN-LONG·Filed 2011·Granted Aug 4, 2015·47 cites·28 claims
- 0696US8680108B2Substituted fused aryl and heteroaryl derivatives as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Mar 25, 2014·62 cites·28 claims
- 0793US9062055B2Fused pyrrole derivatives as PI3K inhibitorsLI YUN-LONG·Filed 2011·Granted Jun 23, 2015·28 cites·18 claims
- 0871US8853243B2Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinasesLI YUN-LONG·Filed 2011·Granted Oct 7, 2014·1 cites·12 claims
- 0950US2007213311A1Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the sameLI YUN-LONG·Filed 2007·Application pending·0 cites
- 1047US2007197530A1Amido compounds and their use as pharmaceuticalsLI YUN-LONG·Filed 2007·Application pending·0 cites
- 1145US2007293529A1Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1LI YUN-LONG·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →